Today: 2 February 2026
Subscribe
Browse Category

Biotechnology News 9 January 2026 - 12 January 2026

BillionToOne stock jumps after fresh 2026 revenue outlook signals faster growth

BillionToOne stock jumps after fresh 2026 revenue outlook signals faster growth

NEW YORK, Jan 12, 2026, 12:58 PM EST — Regular session BillionToOne shares climbed roughly 7% to $92.20 during Monday’s midday session, following the company’s release of its 2026 forecast. The guidance is crucial since the company remains in its early days as a public stock, with investors eager to gauge its growth pace while maintaining profitability. The target is…
12 January 2026
·····
Moderna stock slides as $1.9 billion sales view fails to calm investors (MRNA)

Moderna stock slides as $1.9 billion sales view fails to calm investors (MRNA)

NEW YORK, Jan 12, 2026, 10:25 (ET) — Regular session Moderna (MRNA.O) shares dropped roughly 4% on Monday following the release of updated revenue and expense forecasts ahead of a healthcare investor event. The stock fell $1.38 to $32.92, after starting the day at $34.40 and fluctuating between $35.77 and $32.81. This update is crucial as Moderna works to transition…
12 January 2026
·····
CG Oncology stock (CGON) jumps 29% on faster Phase 3 timeline — what to watch next week

CG Oncology stock (CGON) jumps 29% on faster Phase 3 timeline — what to watch next week

New York, January 11, 2026, 19:47 ET — The market has closed. CG Oncology shares jumped 29.3% to close at $54.20 on Friday, hitting a session high of $57.40 amid increased interest ahead of a critical bladder-cancer readout. Trading volume came in around 7.0 million shares. (Streetinsider) This shift is significant since CG Oncology, a clinical-stage biotech, usually sees its…
12 January 2026
·····
CRISPR Therapeutics stock (CRSP) drops into JPM week — what to watch next

CRISPR Therapeutics stock (CRSP) drops into JPM week — what to watch next

New York, Jan 11, 2026, 17:56 EST — The market has closed for the day. CRISPR Therapeutics AG slipped 4.5% to $53.84 on Friday, putting the gene-editing stock under pressure as biotech leaders and investors gear up to converge in San Francisco this week. (CrisprTx) U.S. markets remain closed Sunday, yet the J.P. Morgan Healthcare Conference frequently shapes the tone…
12 January 2026
···
Regencell Bioscience (RGC) stock swings 45% then closes up 10.6% — what to watch Monday

Regencell Bioscience (RGC) stock swings 45% then closes up 10.6% — what to watch Monday

New York, Jan 11, 2026, 08:22 EST — Market closed. Regencell Bioscience Holdings Ltd shares closed Friday up 10.6% at $45.79, recovering sharply after dipping roughly 15% during the session. The Nasdaq-listed stock kicked off the day at $36.08 and swung between a low of $35.13 and a high of $50.92. U.S. markets were closed Sunday, leaving Monday to reveal…
11 January 2026
·····
Wave Life Sciences stock drops 7% into JPM Healthcare Conference week — what to know next

Wave Life Sciences stock drops 7% into JPM Healthcare Conference week — what to know next

New York, January 10, 2026, 21:25 EST — Market closed Shares of Wave Life Sciences Ltd dropped 6.7% on Friday, ending the day at $13.84. The stock swung between a high of $15.09 and a low of $13.76 during the session. As the J.P. Morgan Healthcare Conference week kicks off, investors are eyeing Wave’s stock for any new insights on…
11 January 2026
·····
CG Oncology stock jumps 29% on faster Phase 3 PIVOT-006 data clock — what to watch next

CG Oncology stock jumps 29% on faster Phase 3 PIVOT-006 data clock — what to watch next

New York, January 10, 2026, 19:54 EST — The market has closed. CG Oncology Inc (CGON) shares surged nearly 29% on Friday, closing at $54.20 after hitting a session high of $57.36. The stock gained $12.25 during the day on volume of about 7.0 million shares. CG Oncology said it now expects “topline” Phase 3 results—the initial look at main…
11 January 2026
·····
Lilly’s TuneLab AI drug platform lands in Schrödinger LiveDesign as biotech access broadens

Lilly’s TuneLab AI drug platform lands in Schrödinger LiveDesign as biotech access broadens

NEW YORK, Jan 10, 2026, 08:12 (EST) Schrödinger announced it will integrate Eli Lilly’s TuneLab, an AI-driven drug discovery platform, into its LiveDesign software. This move offers biotech teams direct access to Lilly’s predictive models. “LiveDesign will be a priority platform partner for TuneLab workflows,” said Pat Lorton, Schrödinger’s software chief. (FinancialContent) The deal comes as drugmakers ramp up AI…
10 January 2026
····
CRISPR Therapeutics stock slides after CFO share-sale filing; JPM conference next

CRISPR Therapeutics stock slides after CFO share-sale filing; JPM conference next

New York, Jan 9, 2026, 15:11 EST — Regular session CRISPR Therapeutics AG shares slid on Friday, bucking a firmer broader market, after a regulatory filing flagged a chief financial officer’s share sale under a pre-arranged trading plan. (Reuters) The company’s CFO, Raju Prasad, exercised stock options for 29,700 common shares and sold 29,700 shares the same day at prices…
9 January 2026
········
Why Regencell Bioscience (RGC) stock is moving today: choppy rebound after Nasdaq pauses

Why Regencell Bioscience (RGC) stock is moving today: choppy rebound after Nasdaq pauses

NEW YORK, Jan 9, 2026, 12:43 EST — Regular session Regencell Bioscience Holdings Limited shares rose about 8.5% to $44.96 in midday trading on Friday, clawing back from an early dip. The stock has swung between $35.13 and $50.92 in the session, with more than 1.1 million shares traded. The bounce keeps attention on RGC after a stretch of sharp…
9 January 2026
····
CG Oncology stock jumps 25% after pulling Phase 3 PIVOT-006 bladder cancer data into 1H 2026

CG Oncology stock jumps 25% after pulling Phase 3 PIVOT-006 bladder cancer data into 1H 2026

New York, Jan 9, 2026, 11:52 EST — Regular session CG Oncology shares jumped on Friday after the company moved up the expected timing for late-stage trial results in bladder cancer. The stock was up 25.1% at $52.45 by 11:52 EST, versus Thursday’s close of $41.93, after trading between $41.63 and $52.64 on the day as volume topped 4.1 million…
9 January 2026
····
Eli Lilly stock (LLY) slips as Ventyx deal, Zepbound arthritis data and TuneLab AI tie-up come into view

Eli Lilly stock (LLY) slips as Ventyx deal, Zepbound arthritis data and TuneLab AI tie-up come into view

New York, Jan 9, 2026, 11:27 EST — Regular trading Eli Lilly and Company (LLY) shares were down about 0.4% at $1,081 in morning trade on Friday. The drugmaker said this week it will buy autoimmune developer Ventyx Biosciences for $1.2 billion in cash, bringing oral candidates for inflammatory bowel disease into its pipeline. The $14-a-share offer is slated to…
9 January 2026
·····
1 … 3 4 5 6 7 … 24

Stock Market Today

  • Parex Resources Shows Continued Rebound in Oil Sector
    February 2, 2026, 8:48 AM EST. Parex Resources continues its rebound amid volatility in the oil and gas industry, known for its cyclical boom-bust cycles. The company's recovery is highlighted by focused investor interest from experienced analysts who emphasize patience and thorough research. With oil prices and midstream segments fluctuating, Parex offers potential value to long-term investors seeking exposure to under-followed energy stocks. This analysis appears with a disclosure of a beneficial long position in Parex shares, underscoring active market engagement but does not constitute investment advice. Investors should conduct their own due diligence when considering Parex Resources for their portfolios.
Go toTop